BioCentury
ARTICLE | Company News

Antisoma, Heraeus Group deal

June 6, 2005 7:00 AM UTC

Heraeus will manufacture clinical trial supplies of ASM's AS1410. ASM expects to start trials of the telomere targeting agent (TTA) for cancer in the first half of 2006. ...